This inventor holds 9 USPTO granted patents and 9 EPO patents. Top assignees: Amderma Pharmaceuticals, LLC, Action Medicines, S.l., Other. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Madred, ES (2013)
- Madrid, ES (2012 - 2016)
Company Filing History:
6 out of 26 
1 out of 3 
2 out of 834,513 Years Active: 2012-2016
Title: Inventor Pedro Cuevas Sánchez: A Leader in Cancer Treatment Innovations
Introduction: Pedro Cuevas Sánchez, based in Madrid, Spain, is a prolific inventor with a remarkable portfolio of 9 patents. His groundbreaking work focuses on innovative methods and compositions for treating various health conditions, including cancer, rosacea, and ocular diseases.
Latest Patents: Among his latest contributions to science are significant inventions related to 2,5-dihydroxybenzene sulfonic acid compounds. One of his notable patents describes methods for treating skin cancer, organ cancer, leukemia, improving chemotherapy efficacy, and addressing rosacea and psoriasis through the administration of his developed compositions. Additionally, he has pioneered the use of these compounds in the treatment of ocular diseases such as macular degeneration and diabetic retinopathy.
Career Highlights: Throughout his career, Pedro has demonstrated an unwavering commitment to advancing medical treatments. His work at Amderma Pharmaceuticals, LLC has been instrumental in channeling innovative therapies from concept to commercialization. His patents not only reflect his creativity but also his dedication to enhancing patient care through scientific discovery.
Collaborations: Pedro Cuevas Sánchez has collaborated with notable professionals in the field, including Guillermo Gimenez Gallego and Serafin Valverde Lopez. These partnerships have undoubtedly fostered innovative approaches to healthcare and contributed to his substantial patent portfolio.
Conclusion: Pedro Cuevas Sánchez stands out as a leading inventor in the medical field, particularly in areas concerning cancer treatment and ocular health. His dedication to innovation and collaboration continues to pave the way for new therapies that promise to improve patient outcomes and exemplify the potential of modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile